Ariana Ba Stuart
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ariana Ba Stuart has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Michelle M. Lawson
Department of Orthopaedics & Rehabilitation, Oregon Health & Sciences University, Portland, Oregon
2 shared publications - Zachary Mark Working
Department of Orthopaedics & Rehabilitation, Oregon Health & Sciences University, Portland, Oregon
2 shared publications - Darin M. Friess
Department of Orthopaedics and Rehabilitation, Oregon Health and Science University, Portland, Oregon
1 shared publication - Duncan C. Ramsey
Assistant Professor, Department of Orthopaedic Surgery, Oregon Health & Science University, Portland, OR, USA
1 shared publication - Emelia Sodders
Department of Orthopaedics and Rehabilitation, Oregon Health & Science University, Portland, Oregon
1 shared publication - Katrina Ramsey
Biostatistics and Design Program, Oregon Health & Science University , Portland, OR
1 shared publication
Latest Publications
- 1 November 2023
- Published by Wolters Kluwer Health in Journal of Orthopaedic Trauma
- Vol. 37 (11) , 586-590
Outcomes of Fracture Surgery in Patients With Escalating Hemoglobin A1C in the Setting of Unmanaged Diabetes
Objective: To determine whether there is a threshold of elevated hemoglobin A1C (HbA1c) above which the complication risk is so high that fracture fixation should be avoided. Design: Retrospective cohort study. Setting: Academic Level I trauma center. Patients/Participants: A cohort of 187 patients with HbA1c values >7 and operatively treated extremity fractures. Intervention: Surgical fixation of extremity fractures. Main Outcome Measurements: Rate of major orthopaedic complication (loss of reduction, nonunion, infection, and need for salvage procedure). Results: 34.8% demonstrated HbA1c > 9% and 12.3% with HbA1c > 11. Major complications occurred in 31.4%; HbA1c values were not predictive. We found no evidence of a clinically or statistically significant relationship between HbA1c and risk of major complication. The odds ratio for a one-point increase in HbA1c was 1.006 (P = 0.9439), and the area under the receiver operating characteristic curve, which reflects the average probability that someone with a major complication will have a higher HbA1c than someone without, was 0.51 (95% confidence interval 0.42–0.61), equivalent to random chance. Conclusion: Diabetic patients with fracture demonstrated an extremely high overall rate of complications, with 30.5% experiencing a major complication. However, patients with extreme diabetic neglect did not have higher complication rates after extremity fracture fixation when compared with patients with controlled and uncontrolled diabetes. There was no correlation between rate of complication and level of HbA1c. In addition, there was no difference in complication rate between upper and lower extremity fractures or between fractures treated with open or percutaneous fixation. This suggests that fracture treatment decision-making should not be altered for patients with poor diabetic control, and that surgery is not contraindicated in patients with an extremely high HbA1c. Level of Evidence: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.
- 1 November 2023
- Published by Wolters Kluwer Health in Journal of Orthopaedic Trauma
- Vol. 37 (11) , 586-590
Outcomes of Fracture Surgery in Patients With Escalating Hemoglobin A1C in the Setting of Unmanaged Diabetes
Objective: To determine whether there is a threshold of elevated hemoglobin A1C (HbA1c) above which the complication risk is so high that fracture fixation should be avoided. Design: Retrospective cohort study. Setting: Academic Level I trauma center. Patients/Participants: A cohort of 187 patients with HbA1c values >7 and operatively treated extremity fractures. Intervention: Surgical fixation of extremity fractures. Main Outcome Measurements: Rate of major orthopaedic complication (loss of reduction, nonunion, infection, and need for salvage procedure). Results: 34.8% demonstrated HbA1c > 9% and 12.3% with HbA1c > 11. Major complications occurred in 31.4%; HbA1c values were not predictive. We found no evidence of a clinically or statistically significant relationship between HbA1c and risk of major complication. The odds ratio for a one-point increase in HbA1c was 1.006 (P = 0.9439), and the area under the receiver operating characteristic curve, which reflects the average probability that someone with a major complication will have a higher HbA1c than someone without, was 0.51 (95% confidence interval 0.42–0.61), equivalent to random chance. Conclusion: Diabetic patients with fracture demonstrated an extremely high overall rate of complications, with 30.5% experiencing a major complication. However, patients with extreme diabetic neglect did not have higher complication rates after extremity fracture fixation when compared with patients with controlled and uncontrolled diabetes. There was no correlation between rate of complication and level of HbA1c. In addition, there was no difference in complication rate between upper and lower extremity fractures or between fractures treated with open or percutaneous fixation. This suggests that fracture treatment decision-making should not be altered for patients with poor diabetic control, and that surgery is not contraindicated in patients with an extremely high HbA1c. Level of Evidence: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.
- 2 December 2020
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 103 (3) , 274-281
Orthopaedic Care of the Transgender Patient
➤ A transgender person is defined as one whose gender identity is incongruent with their biological sex assigned at birth. This highly marginalized population numbers over 1.4 million individuals in the U.S.; this prevalence skews more heavily toward younger generations and is expected to increase considerably in the future. ➤ Gender-affirming hormone therapy (GAHT) has physiologic effects on numerous aspects of the patient’s health that are pertinent to the orthopaedic surgeon, including bone health, fracture risk, and perioperative risks such as venous thromboembolism and infection. ➤ Language and accurate pronoun usage toward transgender patients can have a profound effect on a patient’s experience and on both objective and subjective outcomes. ➤ Gaps in research concerning orthopaedic care of the transgender patient are substantial. Specific areas for further study include the effects of GAHT on fracture risk and healing, outcome disparities and care access across multiple subspecialties, and establishment of perioperative management guidelines.
- 2 December 2020
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 103 (3) , 274-281
Orthopaedic Care of the Transgender Patient
➤ A transgender person is defined as one whose gender identity is incongruent with their biological sex assigned at birth. This highly marginalized population numbers over 1.4 million individuals in the U.S.; this prevalence skews more heavily toward younger generations and is expected to increase considerably in the future. ➤ Gender-affirming hormone therapy (GAHT) has physiologic effects on numerous aspects of the patient’s health that are pertinent to the orthopaedic surgeon, including bone health, fracture risk, and perioperative risks such as venous thromboembolism and infection. ➤ Language and accurate pronoun usage toward transgender patients can have a profound effect on a patient’s experience and on both objective and subjective outcomes. ➤ Gaps in research concerning orthopaedic care of the transgender patient are substantial. Specific areas for further study include the effects of GAHT on fracture risk and healing, outcome disparities and care access across multiple subspecialties, and establishment of perioperative management guidelines.